ARTICLE | Company News
Glaxo Wellcome's Trizivir recommended in Europe
July 18, 2000 7:00 AM UTC
The EMEA's Committee for Proprietary Medicinal Products (CPMP) recommended approval of GLX's Trizivir, a triple combination fixed dosage tablet form of the nucleoside analogs lamivudine, abacavir and ...